News
11h
Zacks Investment Research on MSNTempus AI Gains FDA Nod Amid Booming AI ECG Market Momentum
The integration of artificial intelligence (AI) in the cardiovascular space, particularly in electrocardiography (ECG), is reshaping clinical workflows, enabling earlier disease detection and opening ...
The global ECG Sensor Patches Market, valued at US$0.95 billion in 2024 stood at US$1.05 billion in 2025 and is projected to advance at a resilient CAGR of 12.0% from 2025 to 2032, culminating in a ...
6d
Medical Device Network on MSNFDA grants 510(k) clearance for Tempus AI’s ejection fraction software
The US Food and Drug Administration (FDA) has granted 510(k) clearance for Tempus AI’s ECG-Low (ejection fraction) EF software. This software utilises AI to detect individuals with a low left ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results